Pacira Biosciences Inc. (pcrx 2.125 05/15/29)

13F holders, Q2 2026 (June 30)
3holders
1new positions
1sold out
$1.00avg. 13F price*

At the end of Q2 2026, 3 institutions reported holding Pacira Biosciences Inc. (pcrx 2.125 05/15/29) in their 13F filings, unchanged from Q1 2026. 1 opened new positions and 1 sold out. The largest holders were Absolute Investment Advisers, LLC ($9.0M), Crestwood Advisors Group, LLC ($30K) and Cetera Investment Advisers ($24K).

Company
Pacira Biosciences Inc. (pcrx 2.125 05/15/29)
CUSIP
695127AJ9
Latest filing quarter
Q2 2026

History

Number of 13F holders

0123 Q2 2025: 1Q2 2025Q3 2025: 1Q3 2025Q4 2025: 1Q4 2025Q1 2026: 3Q1 2026Q2 2026: 3Q2 2026

Total Exit/New Position Q1 2026 → Q2 2026

InstitutionsTotal Value
New Positions1$30K
Exits1$3.9M

All 13F filers, Q1 2026 → Q2 2026: 30,000 shares bought and 4,000,000 shares sold, net −3,970,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 3 holders

Absolute Investment Advisers, LLC 0.87% No change 9,000,000 $9.0M
Crestwood Advisors Group, LLC 0.00% New 30,000 $30K
Cetera Investment Advisers 0.00% No change 24,000 $24K

"% of holder's portfolio" is PACIRA BIOSCIENCES INC (PCRX 2.125 05/15/29)'s weight in each manager's 13F, not the share of Pacira Biosciences Inc. (pcrx 2.125 05/15/29) the manager owns.